Find in Library

S155: EFFICACY AND SAFETY RESULTS FROM ASCEMBL, A PHASE 3 STUDY OF ASCIMINIB VS BOSUTINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE AFTER ≥2 PRIOR TYROSINE KINASE INHIBITORS: WK 96 UPDATE

oleh: D. Rea, A. Hochhaus, M. J. Mauro, Y. Minami, E. Lomaia, S. Voloshin, A. Turkina, D.-W. Kim, J. F. Apperley, J. E. Cortes, A. Abdo, L. M. Fogliatto, D. D. H Kim, P. le Coutre, S. Saussele, M. Annunziata, T. P. Hughes, N. Chaudhri, L. Chee, V. García-Gutiérrez, K. Sasaki, S. Kapoor, A. Allepuz, S. Quenet, V. Bédoucha, C. Boquimpani